Your browser doesn't support javascript.
loading
A novel aptasensor platform for the detection of carcinoembryonic antigen using quartz crystal microbalance.
Erkal-Aytemur, Asli; Mülazimoglu, Ibrahim Ender; Üstündag, Zafer; Caglayan, Mustafa Oguzhan.
Afiliación
  • Erkal-Aytemur A; Alanya Alaaddin Keykubat University, R.K. Faculty of Engineering, Fundamental Science, Antalya, Turkey.
  • Mülazimoglu IE; Necmettin Erbakan University, A.K. Education Faculty, Chemistry Department, Konya, Turkey. Electronic address: mulazimoglu@gmail.com.
  • Üstündag Z; Kütahya Dumlupinar University, Faculty of Arts and Science, Department of Chemistry, Kütahya, Turkey.
  • Caglayan MO; Bilecik Seyh Edebali University, Faculty of Engineering, Department of Bioengineering, Bilecik, Turkey. Electronic address: mocaglayan@gmail.com.
Talanta ; 277: 126376, 2024 Sep 01.
Article en En | MEDLINE | ID: mdl-38852341
ABSTRACT
In this study, a quartz crystal microbalance (QCM) aptasensor for carcinoembryonic antigen (CEA), a well-known biomarker for various cancer types, was reported, utilizing two different aptamers. To achieve this, a nanofilm of 4-mercaptophenyl was electrochemically attached to gold-coated QCM crystal surfaces via the reduction of 4-mercaptobenzenediazonium salt (4 MB-DAT) using cyclic voltammetry. Subsequently, gold nanoparticles (AuNP) were affixed to this structure, and then aptamers (antiCEA1 and antiCEA2) modified with SH-functional ends bound to AuNPs completed the modification. The analytical performance of the CEA sensor was evaluated through simultaneous QCM measurements employing CEA solutions ranging from 0.1 ng/mL to 25 ng/mL. The detection limit (LOD) for CEA was determined to be 102 pg/mL for antiCEA1 and 108 pg/mL for antiCEA2 aptamers. Interday and intraday precision and accuracy tests yielded maximum results of 4.3 and + 3.8, respectively, for both aptasensors, as measured by relative standard deviation (RSD%) and relative error (RE%). The kinetic data of the aptasensors resulted in affinity values (KD) of 0.43 ± 0.14 nM for antiCEA1 and 0.75 ± 0.42 nM for antiCEA2. These values were lower than the reported values of 3.9 nM and 37.8 nM for both aptamers, respectively. The selectivity of the aptasensor was evaluated by measuring the signal changes caused by alpha-fetoprotein (AFP), cancer antigen (CA-125), and vascular endothelial growth factor (VEGF-165) individually and together at a concentration of 500 ng/mL, resulting in a maximum 4.1 % change, which was comparable to precision and accuracy values reported in the literature. After confirming the selectivity of the aptamers, recovery experiments were conducted using spiked commercial serum samples to simulate real samples, and the lowest recovery value obtained was 95.4 %. It was determined that two different aptasensors could be successfully used for the QCM-based detection of CEA in this study.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Antígeno Carcinoembrionario / Aptámeros de Nucleótidos / Nanopartículas del Metal / Tecnicas de Microbalanza del Cristal de Cuarzo / Oro Límite: Humans Idioma: En Revista: Talanta Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Técnicas Biosensibles / Antígeno Carcinoembrionario / Aptámeros de Nucleótidos / Nanopartículas del Metal / Tecnicas de Microbalanza del Cristal de Cuarzo / Oro Límite: Humans Idioma: En Revista: Talanta Año: 2024 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Países Bajos